中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 32 Issue 1
Jan.  2016
Turn off MathJax
Article Contents

Risk factors for hyperamylasemia after endoscopic retrograde cholangiopancreatography

DOI: 10.3969/j.issn.1001-5256.2016.01.022
  • Received Date: 2015-05-11
  • Published Date: 2016-01-20
  • Objective To investigate the risk factors for the development of post- endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia( PEPH) after endoscopic retrograde cholangiopancreatography( ERCP). Methods The clinical data of 233 patients who underwent therapeutic ERCP from January 2012 to December 2014 in our hospital and met the inclusion criteria were analyzed retrospectively. Basic information including age,sex,drinking history,single stone,triglyceride,and nationality was extracted,and detailed information on intraoperative procedure,intraoperative diagnosis,and complications for ERCP was carefully recorded. Chi- square test was applied for comparison of categorical data between groups,and Logistic regression analysis were applied to determine the risk factors for the development of PEPH. Results The incidence of PEPH was 26. 6%( 62 /233). Univariate analysis showed that female sex( χ2= 3. 320,P= 0. 045),drinking history( χ2= 6. 108,P = 0. 010),common bile duct stenosis( χ2= 5. 767,P = 0. 012),single stone( χ2= 9. 121,P= 0. 020),juxta- ampullary duodenal diverticula( χ2= 28. 170,P < 0. 001),and abnormal triglyceride( χ2= 54. 717,P < 0. 001) might be the risk factors for PEPH,and these factors differed significantly between the two groups. Multivariate analysis showed that female sex( OR = 1. 616,P = 0. 025) drinking history( OR = 2. 360,P = 0. 010),common bile duct stenosis( OR = 2. 163,P = 0. 012),juxta- ampullary duodenal diverticula( OR = 5. 502,P < 0. 001),and abnormal triglyceride( OR = 12. 924,P < 0. 001) were independent risk factors for PEPH. Conclusion Female sex,drinking history,common bile duct stenosis,juxta- ampullary duodenal diverticula,and abnormal triglyceride are independent risk factors for PEPH,and targeted preventive measures for such high- risk populations can effectively reduce the incidence of PEPH.

     

  • loading
  • [1]JIA YL,JIANG H,HAN Z,et al.Clinical research on the bleeding in ERCP and EST[J].Chin J Clin Pharmacol Ther,2014,19(4):450-453.(in Chinese)贾玉良,姜华,韩真,等.ERCP与EST并发出血的相关临床研究[J].中国临床药理学与治疗学,2014,19(4):450-453.
    [2]YU L,DENG T,ZHAN YJ,et al.The clinical value of ENBD in the prevention of post-ERCP pancreatitis and hyperamylasemia in patients with common bile duct stones[J].Chin J Gastroenterol Hepatol,2012,21(4):316-318.(in Chinese)余璐,邓涛,占义军,等.ENBD预防胆总管结石ERCP术后急性胰腺炎及高淀粉酶血症的临床价值[J].胃肠病学和肝病学杂志,2012,21(4):316-318.
    [3]LI X,MENG W,ZHANG L,et al.Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis:a retrospective analysis of 7,168 cases[J].Pancreatology,2011,11(3):399-405.
    [4]TUENNEMANN J,MSSNER J,BEER S.Acute pancreatitis:guideline-based diagnosis and treatment[J].Internist(Berl),2014,55(9):1045-1056.
    [5]DING BJ,LI S,LIU C,et al.The value of preoperative MRCP on the diagnosis of CBD after cholecystectomy before operating ERCP:an analysis of 139 cases[J].Chin J Pract Intern Med,2015,35(5):449-450.(in Chinese)丁百静,李生,刘充,等.ERCP术前经磁共振胰胆管造影对胆囊切除术后胆总管结石139例诊断价值探讨[J].中国实用内科杂志,2015,35(5):449-450.
    [6]SHAH TU,LIDDLE R,BRANCH MS,et al.Pilot study of aprepitant for pr evention of post-ERCP pancreatitis in high risk patients:a phaseⅡrandomized,double-blind placebo controlled trial[J].JOP,2012,13(2):514-518.
    [7]WANG P,LI ZS,LIU F,et al.Risk factors for ERCP-related complications:a prospective multicenter study[J].Am J Gastroenterol,2009,104(7):31-40.
    [8]TSUJINO T,KOMATSU Y,ISAYAMA H,et al.Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography:a randomized,controlled trial[J].Clin Gastroenterol Hepatol,2005,3(1):376-383.
    [9]ELMUNZER BJ,SCHEIMAN JM,LEHMAN GA,et al.A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis[J].N Engl J Med,2012,366(11):1414-1422.
    [10]KOBAYASHI Y,KANEMITU T,KAMOTO A,et al.Painless acute pancreatitis associated with sorafenib treatment:a case report[J].Med Oncol,2011,28(3):463-465.
    [11]FREEMAN LD,KRIO JA,NDSON VB,et al.Risk factors of post-ERCP pancreatitis:a pmspective,muhicenteraudypl[J].Gastrintesf Eudose,2001,54(4):425-434.
    [12]WANG P,LI ZS,LIU F,et al.Risk factors for ERCP-related complications:a prospective multicenter study[J].Am J Gastroentero,2009,104(1):31-40.
    [13]CHOUDHARY A,BECHTOLD ML,ARIF M,et al.Pancreatic stents for prophylaxis against post-ERCP pancreatitis:a meta-analysis and systematic review[J].Gastrointest Endosc,2011,73(4):275-282.
    [14]LEGHARI A,GHAZANFAR S,QURESHI S,et al.Frequency and risk factors in the post-ERCP pancreatitis in a tertiary care centr[J].J Coll Physicians Surg Pak,2013,23(9):620-624.
    [15]CHEN JJ,WANG XM,LIU XQ,et al.Risk factors for post-ERCP pancreatitis:a systematic review of clinical trials with a large sample size in the past 10 years[J].Eur J Med Res,2014,19(26):1-7.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1770) PDF downloads(432) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return